BridgeMD
New treatment option for Anorexia Nervosa
Official title Effects of rTMS on Food Choice in Anorexia Nervosa
ClinicalTrials.gov ID: NCT05918835
What this study is testing
- What it's testing
- This study will examine the impact of high-frequency repetitive transcranial magnetic stimulation on food choice behavior and related neural activity.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35, women only
You may be able to join if
- DSM-5 Diagnosis of Anorexia Nervosa
- Age 18-35 years
- Female
- Right-handed
- Body Mass Index (BMI) ≥ 16.0
You likely can't join if
- High risk of suicide
- Current substance use disorder or other co- morbid psychiatric condition requiring specialized treatment (e.g., psychosis)
- Diagnosis of major medical or neurological problem or taking medication that significantly increases risk for seizure or affects interpretation of...
- Food restrictions (e.g., allergies) which impact greater than 30% of food choice task's choice options
- Indwelling ferromagnetic metallic object (e.g., pacemaker, pump), non- removable metal jewelry, medicinal patch or recent metallic ink tattoo
- History of seizure
See the full eligibility criteria
- DSM-5 Diagnosis of Anorexia Nervosa
- Age 18-35 years
- Female
- Right-handed
- Body Mass Index (BMI) ≥ 16.0
- Voluntarily admitted to inpatient eating disorders unit at NYSPI
- Competent to provide informed consent
- English-speaking
- Medically stable
- High risk of suicide
- Current substance use disorder or other co- morbid psychiatric condition requiring specialized treatment (e.g., psychosis)
- Diagnosis of major medical or neurological problem or taking medication that significantly increases risk for seizure or affects interpretation of findings (e.g., unstable hypertension, seizure disorder)
- Food restrictions (e.g., allergies) which impact greater than 30% of food choice task's choice options
- Indwelling ferromagnetic metallic object (e.g., pacemaker, pump), non- removable metal jewelry, medicinal patch or recent metallic ink tattoo
- History of seizure
- Diagnosis of epilepsy, stroke, multiple sclerosis, traumatic brain injury, Alzheimer's and other neurodegenerative diseases, meningoencephalitis or intracerebral abscess, or parenchymal or leptomeningeal cancers
- Prior exposure to TMS
- Pregnancy
- Currently breast-feeding
- Significant claustrophobia
- Implanted devices or stimulators
- Hearing loss (e.g., currently undergoing treatment with ototoxic medications or those with cochlear implants)
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 35 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.